TFSA Picks: 1 Healthcare Value Stock with Significant Growth Opportunities

The extent of value-added services provided by Viemed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) should add significant intrinsic company value over the long-term.

| More on:

Viemed Healthcare (TSX:VMD)(NASDAQ:VMD) is a participating medicare durable medical equipment supplier that provides post-acute respiratory care services in the United States. The company operates through two wholly-owned subsidiaries, Sleep Management and Home Sleep.

Viemed’s primary objective is to solidify the company’s position as the largest independent leader in home therapy of patients suffering from respiratory diseases that require a high level of service. The company’s programs are designed specifically for payors to gain the ability to treat patients in the home for less total cost and with a superior quality of care.

Organic growth model

The services of the company’s subsidiaries include respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and respiratory equipment rentals. Viemed adopts an organic growth model whereby expansion is effectuated through existing service areas as well as in new regions through a cost-efficient launch that reduces location expenses.

Viemed employs more respiratory therapists than any other independent provider in the United States. By focusing overhead costs to personnel that service the patient rather than physical location costs, Viemed anticipates efficiently scaling the company’s business in regions that are currently not being effectively serviced.

Significant growth opportunities

The continued trend of servicing patients in the home rather than in hospitals is aligned with Viemed’s vision, and management anticipates that it will continue to offer growth opportunities for Viemed. Viemed expects to continue to be a solution to the rising health costs in the United States by offering more cost-effective home based solutions while increasing the quality of life for patients fighting serious respiratory diseases.

Revenue from ventilator products represented approximately 87% and 92% of total revenues. Viemed’s management believes that the company’s subsidiaries are poised for organic growth moving forward. The company focuses on disease management and improving the quality of life for respiratory patients through clinical excellence, education and technology.

Variety of service offerings

Viemed’s service offerings are based on effective home treatment with respiratory care practitioners providing therapy and counseling to patients at homes using cutting-edge technology. The company’s home sleep division focuses on providing in-home sleep testing for sleep apnea sufferers.

Further, Viemed is one of the largest independent non-invasive ventilator provider in the United States with a service coverage area of 24 states in the United States and prospects to grow. The company’s respiratory disease management service aims at improving quality of life and reducing hospital re-admissions by using proven methodology and leading technologies such as counseling on proper diet, activity level, smoking cessation and inhaler use.

Value-added services

Viemed sources hardware from vendors and pairs them with industry leading respiratory therapy. The company’s neuromuscular care service is focused on helping neuromuscular patients to breathe more comfortably while living an active, healthier life, and uses respiratory therapy treatments which can lessen the effort required to breathe.

Also, the company’s oxygen therapy service provides the patient with extra oxygen, which is sometimes used to manage certain chronic health problems. Overall, the extent of value-added services provided by Viemed should add significant intrinsic company value over the long term.

Fool contributor Nikhil Kumar has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Viemed Healthcare Inc.

More on Investing

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Monday, April 13

After a cooler-than-expected U.S. consumer inflation data lifted the TSX on Friday, today’s session may turn volatile as crude jumps…

Read more »

Retirees sip their morning coffee outside.
Tech Stocks

2 Technology Stocks With the Kind of Potential That Could Make Millionaires

Two tech stocks with impressive growth trajectories amid elevated volatility are potential millionaire-makers.

Read more »

a man celebrates his good fortune with a disco ball and confetti
Dividend Stocks

Where Will Enbridge Stock Be in 3 Years?

Enbridge stock has raised its dividend for 31 straight years. With a $39B project backlog and 5% growth ahead, here's…

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Why the Market May Be too Quick to Write Off These Railway and Telecom Stocks

Discover why the railway and telecom markets are experiencing significant declines and what it means for investors and value growth.

Read more »

Lights glow in a cityscape at night.
Dividend Stocks

2 Dividend Stocks I’d Buy Today and Feel Good Holding for at Least 5 Years

Want dividend income that will last for the five years to come? These two dividend stocks are leaders in Canada.

Read more »

A plant grows from coins.
Dividend Stocks

2 Canadian Dividend Stocks Yielding 4% That Appear to Have the Goods to Back It Up

These Canadian dividend stocks are dependable investments, offer attractive yield of over 4%, and are backed by solid businesses.

Read more »

Investor reading the newspaper
Dividend Stocks

A 3.9% Dividend Stock That Looks Safer Than It Seems

Transcontinental just reshaped its business with a $2.1 billion sale, and that cash could make its dividend look safer than…

Read more »

Young adult concentrates on laptop screen
Retirement

What the Typical 25-Year-Old Canadian Has Saved in a TFSA and RRSP

If you are around 25-years of age, here are some ideas on how to use both your RRSP and TFSA…

Read more »